ArticlePediatric surgery international2026
Post fulguration renal & bladder status (RBS grading) in prognostication of posterior urethral valves.
Article in Pediatric surgery international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimAnatomical classifications of posterior urethral valves (PUV) have limited prognostic utility. We evaluated a Renal & Bladder Status (RBS) grading system, based on early post-treatment renal function and bladder morphology, in predicting long-term outcomes.
methodsA retrospective review of 254 boys treated for PUV between 2003 and 2023 was performed. RBS-0 included non-classical/ suspected valves; RBS-1 classical PUV with preserved renal/bladder function (nadir creatinine <1 mg/dl and bladder contour normal); RBS-2 impaired but recoverable renal/bladder function (nadir creatinine <1 mg/dl and bladder contour improves) after fulguration; and RBS-3 persistent dysfunction (nadir creatinine >1 mg/dl or bladder contour abnormal/ persistent VUR) despite treatment. Primary outcome was progression to end-stage renal disease (ESRD); secondary outcome was valve bladder (VB). Kaplan-Meier survival and Cox proportional hazards models assessed predictors of ESRD.
resultsESRD occurred in 0% of RBS-0, 6.3% of RBS-1, 12.2% of RBS-2, and 51.7% of RBS-3 (p < 0.001). VB developed in 0%, 4.7%, 8.8%, and 41.3% respectively (p < 0.001). At 10 years, ESRD-free survival was 95% (RBS-0), 85% (RBS-1), 65% (RBS-2), and 35% (RBS-3) (log-rank p < 0.001). On multivariable Cox analysis, RBS-2 (HR 3.1, 95% CI 1.4-6.8), RBS-3 (HR 6.7, 95% CI 3.2-14.0), nadir creatinine > 1 mg/dL (HR 2.5, 95% CI 1.5-4.2), and high-grade VUR (HR 1.9, 95% CI 1.1-3.4) independently predicted ESRD, while age at presentation was not significant.
conclusionRBS grading, incorporating early renal and bladder recovery after treatment, provides prognostic information and enables early risk stratification in PUV. Larger prospective multi-center studies are warranted to validate RBS grading.
Indexed as
Identifiers
41721851What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.